These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8558116)

  • 1. Unilateral nasal infection of cotton rats with respiratory syncytial virus allows assessment of local and systemic immunity.
    Johnson SA; Ottolini MG; Darnell ME; Porter DD; Prince GA
    J Gen Virol; 1996 Jan; 77 ( Pt 1)():101-8. PubMed ID: 8558116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cotton rat model of effectors of immunity to respiratory syncytial virus other than serum antibody.
    Piazza FM; Schmidt HJ; Johnson SA; Dotson DL; Darnell ME; Ottolini MG; Porter DD; Prince GA
    Pediatr Pulmonol; 1995 Jun; 19(6):355-9. PubMed ID: 7567215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment.
    Power UF; Plotnicky-Gilquin H; Huss T; Robert A; Trudel M; Ståhl S; Uhlén M; Nguyen TN; Binz H
    Virology; 1997 Apr; 230(2):155-66. PubMed ID: 9143271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.
    Shafique M; Wilschut J; de Haan A
    Vaccine; 2012 Jan; 30(3):597-606. PubMed ID: 22120195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment.
    Boukhvalova MS; Yim KC; Kuhn KH; Hemming JP; Prince GA; Porter DD; Blanco JC
    J Infect Dis; 2007 Feb; 195(4):511-8. PubMed ID: 17230410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmid DNA encoding the respiratory syncytial virus G protein is a promising vaccine candidate.
    Li X; Sambhara S; Li CX; Ettorre L; Switzer I; Cates G; James O; Parrington M; Oomen R; Du RP; Klein M
    Virology; 2000 Mar; 269(1):54-65. PubMed ID: 10725198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual administration of a helper-dependent adenoviral vector expressing the codon-optimized soluble fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in mice.
    Fu YH; Jiao YY; He JS; Giang GY; Zhang W; Yan YF; Ma Y; Hua Y; Zhang Y; Peng XL; Shi CX; Hong T
    Antiviral Res; 2014 May; 105():72-9. PubMed ID: 24560779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic and immunogenic analysis of group A and group B respiratory syncytial virus G proteins expressed from recombinant baculoviruses.
    Sullender WM; Britt WJ
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():641-8. PubMed ID: 8627252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats.
    Wyde PR; Moore DK; Hepburn T; Silverman CL; Porter TG; Gross M; Taylor G; Demuth SG; Dillon SB
    Pediatr Res; 1995 Oct; 38(4):543-50. PubMed ID: 8559607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of non-viral antigens in the cotton rat model of respiratory syncytial virus vaccine-enhanced disease.
    Shaw CA; Galarneau JR; Bowenkamp KE; Swanson KA; Palmer GA; Palladino G; Markovits JE; Valiante NM; Dormitzer PR; Otten GR
    Vaccine; 2013 Jan; 31(2):306-12. PubMed ID: 23153444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
    Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
    J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
    Zeng R; Qi X; Gong W; Mei X; Wei L; Ma C; Yin X
    Vaccine; 2007 Oct; 25(42):7422-8. PubMed ID: 17850930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical modelling identifies the role of adaptive immunity as a key controller of respiratory syncytial virus in cotton rats.
    Wethington D; Harder O; Uppulury K; Stewart WCL; Chen P; King T; Reynolds SD; Perelson AS; Peeples ME; Niewiesk S; Das J
    J R Soc Interface; 2019 Nov; 16(160):20190389. PubMed ID: 31771450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of RSVIG prophylaxis and therapy of respiratory syncytial virus in an immunosuppressed animal model.
    Ottolini MG; Porter DD; Hemming VG; Zimmerman MN; Schwab NM; Prince GA
    Bone Marrow Transplant; 1999 Jul; 24(1):41-5. PubMed ID: 10435733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of antibody, complement and cellular immunity in the pathogenesis of enhanced respiratory syncytial virus disease.
    Delgado MF; Polack FP
    Expert Rev Vaccines; 2004 Dec; 3(6):693-700. PubMed ID: 15606354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in and the potential of vaccines for respiratory syncytial virus.
    Jorquera PA; Oakley KE; Tripp RA
    Expert Rev Respir Med; 2013 Aug; 7(4):411-27. PubMed ID: 23964629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric subgroup A respiratory syncytial virus with the glycoproteins substituted by those of subgroup B and RSV without the M2-2 gene are attenuated in African green monkeys.
    Cheng X; Zhou H; Tang RS; Munoz MG; Jin H
    Virology; 2001 Apr; 283(1):59-68. PubMed ID: 11312662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
    Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
    J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
    Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S
    Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant forms of the F protein of human respiratory syncytial (RS) virus induce a cytotoxic T lymphocyte response but not a neutralizing antibody response and only transient resistance to RS virus infection.
    Gaddum RM; Cook RS; Wyld SG; López JA; Bustos R; Melero JA; Taylor G
    J Gen Virol; 1996 Jun; 77 ( Pt 6)():1239-48. PubMed ID: 8683212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.